Jan 13 (Reuters) - Genscript Biotech Corp :
* GENSCRIPT SUBMITS APPLICATION WITH FDA FOR USE OF CPASS™ SARS-COV-2 NEUTRALIZATION ANTIBODY TEST IN CONVALESCENT PLASMA SCREENING
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
精彩评论